In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...

At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

Unlike traditional testing, which requires hundreds or thousands of charge – discharge cycles, the model can estimate a new ...

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.

Since the dawn of the computer age, researchers have wrestled with two persistent challenges: how to store ever-increasing ...

The government is asking experts and academics to help shape a plan to tackle the growing issue of deepfakes, ITV News ...

It’s no longer about hiring specialists. The market now demands hybrid marketers: people who can speak to both business goals ...

Evolving toxicity assessments for engineered nanoparticles underline the importance of predictive models and life-cycle risk ...

AI-based procurement software is used by organisations for sourcing goods, managing suppliers, and managing overall spend.

The degradation is subtle but cumulative. Tools that release frequent updates while training on datasets polluted with ...